Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Orthopediatrics Corp (KIDS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: KIDS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -52.79% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 638.98M USD | Price to earnings Ratio - | 1Y Target Price 39 |
Price to earnings Ratio - | 1Y Target Price 39 | ||
Volume (30-day avg) 237562 | Beta 1.22 | 52 Weeks Range 21.02 - 35.99 | Updated Date 04/2/2025 |
52 Weeks Range 21.02 - 35.99 | Updated Date 04/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.64 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-03-04 | When After Market | Estimate -0.2567 | Actual -0.29 |
Profitability
Profit Margin -18.47% | Operating Margin (TTM) -16.26% |
Management Effectiveness
Return on Assets (TTM) -4.05% | Return on Equity (TTM) -10.34% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 612662079 | Price to Sales(TTM) 3.12 |
Enterprise Value 612662079 | Price to Sales(TTM) 3.12 | ||
Enterprise Value to Revenue 2.99 | Enterprise Value to EBITDA -79.86 | Shares Outstanding 24286600 | Shares Floating 16154225 |
Shares Outstanding 24286600 | Shares Floating 16154225 | ||
Percent Insiders 32.42 | Percent Institutions 71.18 |
Analyst Ratings
Rating 4.17 | Target Price 40.17 | Buy 3 | Strong Buy 2 |
Buy 3 | Strong Buy 2 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Orthopediatrics Corp
Company Overview
History and Background
Orthopediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana. The company focuses on developing and marketing orthopedic implants and instruments exclusively for children.
Core Business Areas
- Trauma & Deformity: This segment offers products for fracture fixation, limb lengthening, and correction of deformities in children.
- Spine: Focuses on solutions for pediatric spinal deformities, including scoliosis and kyphosis.
- Sports Medicine/Other: Provides specialized products and instruments for sports-related injuries and other orthopedic needs in children.
Leadership and Structure
Mark Throdahl serves as the CEO and President. The company has a board of directors overseeing its strategic direction. The structure includes sales, marketing, R&D, operations, and finance departments.
Top Products and Market Share
Key Offerings
- PediLoc Pediatric Plating System: A comprehensive plating system for pediatric fractures. While exact market share data is not publicly available, Orthopediatrics holds a significant share within the niche pediatric orthopedic market. Competitors include DePuy Synthes (JNJ) and Stryker (SYK), but their pediatric-specific offerings are less extensive.
- Response Scoliosis System: A spinal deformity correction system tailored for young patients. Market share data is not directly disclosed. Competitors include Medtronic (MDT) and NuVasive (NUVA), but Orthopediatrics focuses solely on the pediatric segment which gives them an edge. Revenue attributable to Response Scoliosis System is not publicly available.
Market Dynamics
Industry Overview
The pediatric orthopedic market is a specialized segment within the broader orthopedic industry. It is characterized by specific needs related to growing bones and children's physiology. It is a growing market driven by increasing awareness and the development of specialized implants.
Positioning
Orthopediatrics is a leader in the pediatric orthopedic market, specializing exclusively in children's needs. Its competitive advantage lies in its focused expertise and portfolio of products designed specifically for pediatric patients.
Total Addressable Market (TAM)
The pediatric orthopedic market is estimated to be in the hundreds of millions of dollars. Orthopediatrics is well-positioned to capture a significant portion of this TAM due to its specialized focus.
Upturn SWOT Analysis
Strengths
- Specialized focus on pediatric orthopedics
- Comprehensive product portfolio tailored for children
- Strong relationships with pediatric orthopedic surgeons
- Innovative product development
- Strong brand recognition in the pediatric orthopedic market
Weaknesses
- Smaller size compared to larger orthopedic companies
- Limited resources for extensive marketing campaigns
- Dependence on a niche market
- Lower profit margins relative to large cap healthcare
Opportunities
- Expanding product offerings in existing markets
- Entering new geographic markets
- Developing new technologies and implants
- Acquiring smaller companies with complementary products
- Increasing awareness of pediatric-specific orthopedic solutions
Threats
- Competition from larger orthopedic companies
- Changes in reimbursement policies
- Product liability lawsuits
- Economic downturn affecting healthcare spending
- Consolidation of hospitals and healthcare systems
Competitors and Market Share
Key Competitors
- JNJ
- MDT
- SYK
Competitive Landscape
Orthopediatrics competes with larger orthopedic companies, but its exclusive focus on pediatric patients provides a competitive advantage. However, it faces challenges in terms of resources and market reach.
Major Acquisitions
Response Orthopedics
- Year: 2022
- Acquisition Price (USD millions): 37.5
- Strategic Rationale: Expanded Orthopediatrics' scoliosis offerings and strengthened its position in the pediatric spine market.
Growth Trajectory and Initiatives
Historical Growth: Orthopediatrics has experienced revenue growth over the past several years, driven by increased adoption of its products and expansion into new markets.
Future Projections: Analysts expect continued revenue growth for Orthopediatrics, driven by increasing demand for pediatric orthopedic solutions. Profitability improvements are anticipated, but not guaranteed.
Recent Initiatives: Recent initiatives include new product launches and strategic partnerships to expand its market reach. They have been expanding into areas of sports medicine and trauma repair
Summary
Orthopediatrics is a leading player in the niche market of pediatric orthopedics, driven by its focus on developing solutions for children. While smaller than its competitors, it has a focused approach and innovative products. They are continuing to grow revenue, however, net income is still lacking and needs to be corrected. Competition from larger companies and changes in the industry need to be closely monitored.
Similar Companies
JNJ
Johnson & Johnson
JNJ
Johnson & Johnson
MDT
Medtronic PLC
MDT
Medtronic PLC
SYK
Stryker Corporation
SYK
Stryker Corporation
ZBH
Zimmer Biomet Holdings Inc
ZBH
Zimmer Biomet Holdings Inc
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Company Website
- Market Research Reports
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthopediatrics Corp
Exchange NASDAQ | Headquaters Warsaw, IN, United States | ||
IPO Launch date 2017-10-12 | President, CEO & Director Mr. David R. Bailey | ||
Sector Healthcare | Industry Medical Devices | Full time employees 562 | Website https://www.orthopediatrics.com |
Full time employees 562 | Website https://www.orthopediatrics.com | ||
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.